Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence
of antiphospholipid antibodies (aPL)(lupus anticoagulant, anticardiolipin antibodies and anti …

Objective This study aimed to elucidate the presence, antigen specificities, and potential
clinical associations of anti–neutrophil extracellular trap (anti‐NET) antibodies in a …

In the early phase of the pandemic, we were among the first to postulate that neutrophil
extracellular traps (NETs) play a key role in COVID‐19 pathogenesis. This exploratory …

Numerous studies suggest that neutrophils might have a crucial role in the pathogenesis of
systemic autoimmune diseases through neutrophil extracellular trap (NET) formation …

Neutrophil hyperactivity and neutrophil extracellular trap release (NETosis) appear to play
important roles in the pathogenesis of the thromboinflammatory autoimmune disease known …

Objective Pathogenesis of antiphospholipid syndrome (APS) isn't fully elucidated. We aimed
to identify gene signatures characterizing thrombotic primary APS (thrPAPS) and subgroups …

Importance The prevalence of antiphospholipid antibodies (aPL) and their association with
future atherosclerotic cardiovascular disease (ASCVD) risk has yet to be thoroughly …

We previously reported that treatment of mice with 6-gingerol, the most abundant
phytochemical in ginger root, leads to phosphodiesterase inhibition that counteracts …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by
recurrent vascular thrombosis and miscarriages in the absence of known causes. Antibodies …